Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,020
Closed -$203K 331
2019
Q3
$203K Buy
+4,020
New +$198K 0.06% 343
2019
Q2
Sell
-4,477
Closed -$217K 363
2019
Q1
$217K Buy
+4,477
New +$202K 0.06% 349
2018
Q4
Sell
-7,034
Closed -$288K 388
2018
Q3
$288K Buy
7,034
+34
+0.5% +$1.37K 0.04% 406
2018
Q2
$278K Sell
7,000
-56
-0.8% -$2.15K 0.04% 403
2018
Q1
$264K Buy
7,056
+27
+0.4% +$1.09K 0.04% 411
2017
Q4
$300K Sell
7,029
-171
-2% -$6.82K 0.04% 391
2017
Q3
$264K Buy
7,200
+349
+5% +$14.1K 0.04% 411
2017
Q2
$311K Buy
6,851
+8
+0.1% +$353 0.05% 353
2017
Q1
$291K Buy
6,843
+77
+1% +$3.14K 0.05% 360
2016
Q4
$271K Sell
6,766
-54
-0.8% -$2.08K 0.05% 364
2016
Q3
$265K Buy
6,820
+916
+16% +$34.6K 0.05% 373
2016
Q2
$204K Sell
5,904
-269
-4% -$9.31K 0.04% 422
2016
Q1
$213K Buy
+6,173
New +$215K 0.05% 415

Other funds holding HOLX

ClearArc Capital's HOLX Position: Q4 2019 in Review

ClearArc Capital sold out of Hologic (HOLX) in Q4 2019, closing a stake of 4,020 shares — an estimated $203K sold.

ClearArc Capital first reported a position in HOLX in Q1 2016 and held it in 13 quarters. The position peaked at $311K in Q2 2017. 520 funds tracked by Wall St. Rank hold HOLX as of Q4 2019.

  • ClearArc Capital reported no remaining Hologic position as of Q4 2019 after selling out during the quarter.
  • ClearArc Capital sold 4,020 Hologic shares in Q4 2019, an estimated $203K.
  • ClearArc Capital first reported a position in Hologic in Q1 2016 and held it in 13 quarters.
  • ClearArc Capital's Hologic position peaked at $311K in Q2 2017.
  • 520 funds tracked by Wall St. Rank held Hologic as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.